AR053576A1 - Uso de inhibidores de rceptor de factor de crecimiento endotelial vascular para el tratamiento de canceres gastrointestinal, genitourinario, linfoide y pulmonar - Google Patents
Uso de inhibidores de rceptor de factor de crecimiento endotelial vascular para el tratamiento de canceres gastrointestinal, genitourinario, linfoide y pulmonarInfo
- Publication number
- AR053576A1 AR053576A1 ARP060101427A ARP060101427A AR053576A1 AR 053576 A1 AR053576 A1 AR 053576A1 AR P060101427 A ARP060101427 A AR P060101427A AR P060101427 A ARP060101427 A AR P060101427A AR 053576 A1 AR053576 A1 AR 053576A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- substituted
- formula
- hydroxy
- alkyl
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title abstract 2
- 208000020816 lung neoplasm Diseases 0.000 title abstract 2
- 239000003102 growth factor Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000002792 vascular Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- -1 cyano, carboxy Chemical group 0.000 abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- WHOWNXIYXLWMGJ-UHFFFAOYSA-N 1-(pyridin-4-ylmethyl)phthalazine Chemical class N=1N=CC2=CC=CC=C2C=1CC1=CC=NC=C1 WHOWNXIYXLWMGJ-UHFFFAOYSA-N 0.000 abstract 1
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 abstract 1
- 206010025323 Lymphomas Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241000534944 Thia Species 0.000 abstract 1
- 208000008385 Urogenital Neoplasms Diseases 0.000 abstract 1
- 229940124674 VEGF-R inhibitor Drugs 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000933 neural crest Anatomy 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical class 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67087005P | 2005-04-13 | 2005-04-13 | |
| US68039605P | 2005-05-12 | 2005-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR053576A1 true AR053576A1 (es) | 2007-05-09 |
Family
ID=36649704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060101427A AR053576A1 (es) | 2005-04-13 | 2006-04-11 | Uso de inhibidores de rceptor de factor de crecimiento endotelial vascular para el tratamiento de canceres gastrointestinal, genitourinario, linfoide y pulmonar |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR053576A1 (fr) |
| GT (1) | GT200600147A (fr) |
| PE (1) | PE20061361A1 (fr) |
| TW (1) | TW200719914A (fr) |
| UY (1) | UY29471A1 (fr) |
| WO (1) | WO2006113172A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0610925D0 (en) * | 2006-06-02 | 2006-07-12 | Novartis Ag | Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
-
2006
- 2006-04-10 GT GT200600147A patent/GT200600147A/es unknown
- 2006-04-10 WO PCT/US2006/013056 patent/WO2006113172A1/fr not_active Ceased
- 2006-04-11 UY UY29471A patent/UY29471A1/es not_active Application Discontinuation
- 2006-04-11 AR ARP060101427A patent/AR053576A1/es not_active Application Discontinuation
- 2006-04-12 TW TW095113028A patent/TW200719914A/zh unknown
- 2006-04-17 PE PE2006000398A patent/PE20061361A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200719914A (en) | 2007-06-01 |
| WO2006113172A1 (fr) | 2006-10-26 |
| GT200600147A (es) | 2006-11-24 |
| UY29471A1 (es) | 2006-11-30 |
| PE20061361A1 (es) | 2007-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR077849A2 (es) | Compuestos y composiciones como inhibidores de proteina quinasa | |
| CY1113002T1 (el) | Παραγωγα μακροκυκλικης κιναζολινης ως αντιπολλαπλασιαστικοι παραγοντες | |
| CO5590894A2 (es) | Derivados de a-(n-sulfonamido)acetamida como inhibidores del peptido b-amiloideo | |
| AR114244A1 (es) | Compuestos que degradan efgr útiles en el tratamiento del cáncer | |
| ID23698A (id) | Ftalazin dengan aktifitas penghambatan angiogenesis | |
| RU2008129683A (ru) | Ингибиторы iap | |
| PE20110153A1 (es) | Derivados de piridazina como inhibidores de smo | |
| CO6231028A2 (es) | Compuestos y composiciones como inhibidores de la proteina quinasa | |
| AR068121A1 (es) | Compuestos multiciclicos para tratar enfermedades neurodegenerativas | |
| CO6241115A2 (es) | Compuestos y composiciones como inhibidores de protein quinasas | |
| GT200500218A (es) | Derivados de triazolopiridinilsulfanilo como inhibidores de quinasa map p38 | |
| AR042956A1 (es) | Inhibidores de girasa y usos de los mismos | |
| TR201900306T4 (tr) | Mek inhibitörlerini kullanma yöntemleri. | |
| CY1113911T1 (el) | Παραγωγα sf5 ως αναστολεις par1, η παρασκευη τους και η χρηση τους ως φαρμακα | |
| CY1110232T1 (el) | Παραγωγα 2-αρυλ-6-φαινυλ-ιμιδαζο[1,2-α]πυριδιν, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη | |
| AR053120A1 (es) | Aminopiridinas como inhibidores de beta secretasa | |
| CY1116208T1 (el) | Υδατο-διαλυτη ενωση βενζοαζεπινης και η φαρμακευτικη συνθεση αυτης | |
| AR116483A1 (es) | Inhibidores de egfr de quinazolina | |
| AR055756A1 (es) | Piperidinas sustituidas; procesos de preparacion y su uso como medicamentos | |
| CO5611194A2 (es) | Inhibidores novedosos de la farnesil proteina transferasa como agentes antitumorales | |
| CO5060426A1 (es) | 1-aril-3-imidiopirazoles plaguicidas | |
| CO5690592A2 (es) | 5-arilpirimidinas como agentes anticancer | |
| RU2009102974A (ru) | Средство, потенцирующее радиационную терапию | |
| AR053576A1 (es) | Uso de inhibidores de rceptor de factor de crecimiento endotelial vascular para el tratamiento de canceres gastrointestinal, genitourinario, linfoide y pulmonar | |
| AR049861A1 (es) | Derivados de bencimidazol, procesos de preparacion y composiciones farmaceuticas que los co0ntienen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |